Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001566377 | SCV001789882 | likely benign | not provided | 2022-06-20 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
Labcorp Genetics |
RCV001566377 | SCV002337794 | benign | not provided | 2024-01-02 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001566377 | SCV005217290 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003966201 | SCV004786970 | likely benign | P2RX2-related disorder | 2019-04-05 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |